HTA Database - Search Results

Sort by Relevance

Search Results [967 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: standards for the management of acute ST-segment elevation myocardial infarction (STEMI) in Québec (update of April 2021)]
2021	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Newborn screening for classic congenital adrenal hyperplasia. Update and assessment of regional programs]
2021	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Bedaquiline (new therapeutic indication: pulmonary multidrug-resistant tuberculosis, 5 to 11 years)]
2021	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Fenfluramine (Dravet syndrome, ≥ 2 years)]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: initiating pharmacotherapy for relapse prevention in a person with alcohol use disorder]
2021	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Ivacaftor/Tezacaftor/Elexacaftor (Exceeding the € 50 Million Limit, Cystic Fibrosis, Combination Treatment with Ivacaftor in Patients 12 Years and Older (Heterozygous for F508del and MF Mutation))]
2021	NIHR Health Services and Delivery Research programme	Progressive exercise compared with best-practice advice, with or without corticosteroid injection, for rotator cuff disorders: the GRASP factorial RCT
2021	Malaysian Health Technology Assessment (MaHTAS)	Hyperthermic intraperitoneal chemotherapy as an adjuvant therapy for peritoneal surface malignancy (PSM)
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of neonatal pulse oximetry screening for critical congenital heart disease]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: assessment and risk management of severe neurological complications following mild traumatic brain injury]
2021	Austrian Institute for Health Technology Assessment (AIHTA)	Allogenic bone screw Shark Screw® in patients with hallux valgus or scaphoid fractures/pseudarthroses: systematic review
2021	Austrian Institute for Health Technology Assessment (AIHTA)	[Non-interventional studies (NIS) in Austria, 2nd update of systematic analyses 2016 & 2017]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: evolving profile of the use and clinical outcomes of transcatheter aortic valve implantation (TAVI) and surgical aortic valve implantation (SAVR) in Québec, a real-world evaluation from 2013 to 2019]
2021	Belgian Health Care Knowledge Centre (KCE)	Benefits and costs of innovative oncology drugs in Belgium (2004-2017)
2021	Ontario Health	Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment
2021	Health Information and Quality Authority (HIQA)	Health technology assessment of birth cohort testing for hepatitis C
2021	Ontario Health	Stance-control knee–ankle–foot orthoses for people with knee instability: a health technology assessment
2021	Swiss Federal Office of Public Health (FOPH)	Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: needs analysis grid for families followed by Integrated Perinatal and Early Childhood Services (SIPPE)]
2021	Swiss Federal Office of Public Health (FOPH)	The treatment of hypercholesterolaemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines
2021	Belgian Health Care Knowledge Centre (KCE)	Long COVID: Pathophysiology – epidemiology and patient needs
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: creation and characterization of a Québec lung cancer patient cohort using clinical administrative data]
2021	Ontario Health	Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: consent process and disposition options for embryos preserved following in vitro fertilization]
2021	Austrian Institute for Health Technology Assessment (AIHTA)	[Nivolumab in malignant melanoma: contrasting the evidence from pivotal trials with real world evidence (RWE)]
2021	Ontario Health	Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure
2021	Health Technology Wales (HTW)	Point-of-care ultrasound to diagnose gallstone disease
2020	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Effectiveness and safety of endovascular treatment with venous adhesive in varicose veins of the lower extremities]
2020	Adelaide Health Technology Assessment (AHTA)	Detection of aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein antibody (MOG) antibodies for diagnosis of neuromyelitis optica (NMO) and myelin oligodendrocyte glycoprotein antibody-related demyelination (MARD)
2020	Andalusian Health Technology Assessment Area (AETSA)	[C-Reactive Protein point-of-care testing (CRP-POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections]
2020	Norwegian Institute of Public Health (NIPH)	Intracoronary lithotripsy for the treatment of coronary artery disease: a health technology assessment
2020	NIHR Health Technology Assessment programme	Interventions to reduce the risk of surgically transmitted Creutzfeldt–Jakob disease: a cost-effective modelling review
2020	Malaysian Health Technology Assessment (MaHTAS)	Pre-dialysis education programme (PDEP)
2020	Malaysian Health Technology Assessment (MaHTAS)	Diagnostic approaches to solitary pulmonary nodule (SPN)
2020	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Safety and efficacy of Thai massage as a therapeutic intervention in clinical pathologies]
2020	Malaysian Health Technology Assessment (MaHTAS)	Cinacalcet for the treatment of secondary hyperparathyroidism in end stage renal failure and economic evaluation
2020	Malaysian Health Technology Assessment (MaHTAS)	Influenza vaccination for the elderly and economic evaluation
2020	Malaysian Health Technology Assessment (MaHTAS)	Intravenous iron for iron deficiency anaemia
2020	Malaysian Health Technology Assessment (MaHTAS)	Programmatic management of latent tuberculosis infection
2020	Malaysian Health Technology Assessment (MaHTAS)	Digital dental impression
2020	Malaysian Health Technology Assessment (MaHTAS)	Biocompatible peritoneal dialysis (PD) solution
2020	Health Technology Wales (HTW)	Autologous haematopoietic stem cell transplantation for previously treated, relapsing-remitting multiple sclerosis
2020	Malaysian Health Technology Assessment (MaHTAS)	Acupuncture for headache, refractory neuralgia, Bell’s palsy, post-stroke, Guillain barre and transverse myelitis
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Effectiveness and safety of the left ventricular assist device (LVAD) as destination therapy in paediatric patients]
2020	The Regional Health Technology Assessment Centre (HTA-centrum)	Magnetic resonance image-guided radiotherapy in patients with cancer in thorax, abdomen, pelvis or head and neck
2020	NIHR Health Services and Delivery Research programme	Social norms interventions to change clinical behaviour in health workers: a systematic review and meta-analysis
2020	Malaysian Health Technology Assessment (MaHTAS)	Prophylactic anticoagulation in ambulatory cancer patients
2020	NIHR Health Technology Assessment programme	Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation
2020	Scottish Health Technologies Group (SHTG)	Dxcover brain cancer liquid biopsy test for early brain cancer detection in primary care
2020	National Committee for Technology Incorporation (CONITEC)	[Mirabegron for the treatment of storage dysfunction in patients with neurogenic bladder]
2020	National Committee for Technology Incorporation (CONITEC)	[Antimuscarinics (oxybutynin, tolterodine, solifenacin and darifenacin) for the treatment of storage dysfunction in patients with neurogenic bladder]
2020	National Committee for Technology Incorporation (CONITEC)	[Targeted therapies (vemurafenib, dabrafenib, cobimetinib, trametinib) and immunotherapies (ipilimumab, nivolumab, pembrolizumab) for the first-line treatment of advanced (unresectable and metastatic) melanoma]
2020	NIHR Health Services and Delivery Research programme	Effects of increased distance to urgent and emergency care facilities resulting from health services reconfiguration: a systematic review
2020	Ontario Health	Cell-Free Circulating Tumour DNA Blood Testing to Detect EGFR T790M Mutation in People With Advanced Non–Small Cell Lung Cancer: A Health Technology Assessment
2020	Institute for Clinical Effectiveness and Health Policy (IECS)	[Volumetric modulated arc therapy in patients with lung cancer, prostate cancer, high-risk gliomas and tumors in head and neck]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in August 2020: administration of drugs prescribed via an individual prescription in the event of distress for a person receiving palliative care]
2020	Ontario Health	Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: safety of switching biologics and their interchangeability]
2020	NIHR Health Technology Assessment programme	Medically unexplained symptoms(MUS): primary care intervention
2020	NIHR Health Technology Assessment programme	Pre-Operative Behavioural Intervention to Reduce Drinking before elective orthopaedic Surgery (Pre-Op BIRDS)
2020	NIHR Health Technology Assessment programme	Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: evolving portrait of the use and clinical outcomes of transcatheter aortic valve implantation (TAVI) in Québec, an evaluation in the real-world context of care, 2013 to 2018]
2020	NIHR Health Technology Assessment programme	Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation
2020	NIHR Health Services and Delivery Research programme	An evaluation of alcohol treatment centres: implications for service delivery, patient benefit and harm reduction
2020	Malaysian Health Technology Assessment (MaHTAS)	Targeted therapies in combination with hormonal therapy as a first-line treatment for HR+ and HER2- metastatic breast cancer
2020	Malaysian Health Technology Assessment (MaHTAS)	Refurbished medical device
2020	Malaysian Health Technology Assessment (MaHTAS)	Resuscitative endovascular balloon occlusion of the aorta (REBOA)
2020	Malaysian Health Technology Assessment (MaHTAS)	Transbronchial cryobiopsy for lung biopsy in interstitial lung disease
2020	Malaysian Health Technology Assessment (MaHTAS)	Hepatitis C virus screening and surveillance tests for dialysis patients
2020	Andalusian Health Technology Assessment Area (AETSA)	Genetic risk prediction test for cardiovascular disease
2020	Canary Health Service	[HPV vaccination in adolescent boys: cost-effectiveness and budget impact]
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical Efectiveness of Newborn Screening for Inborn Errors of Metabolism by MS/ MS. Update and pilot study assessment: Maple Syrup Urine Disease; Isovaleric Acidaemia; Homocystinuria]
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Treatment of benign thyroid by thermal laser or radiofrequency ablation]
2020	NIHR Health Technology Assessment programme	Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review
2020	NIHR Health Services and Delivery Research programme	Medication management in older people: the MEMORABLE realist synthesis
2020	Malaysian Health Technology Assessment (MaHTAS)	Pulsed electromagnetic field therapy – an update
2020	Malaysian Health Technology Assessment (MaHTAS)	Repetitive transcranial magnetic stimulation (rTMS) for patients with stroke
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Proposal for the organization of bariatric medicine for the territories of the integrated university health and social services network of Laval University]
2020	NIHR Health Services and Delivery Research programme	ERA Electronic Records in Ambulances to support the shift to out of hospital care: challenges, opportunities and workforce implications
2020	NIHR Health Services and Delivery Research programme	Dementia undetected or undiagnosed in primary care: the prevalence, causes and consequences
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tomosynthesis and breast cancer: diagnostic evaluation and other uses]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: first-line treatment of oral candidiasis in adults]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: initiating a blood profile after detecting suggestive symptoms and signs of mild or major neurocognitive disorder]
2020	NIHR Health Services and Delivery Research programme	Optimising acute care for people with dementia: a mixed-methods study
2020	Basque Office for Health Technology Assessment (OSTEBA)	[Neonatal hearing screening programmes: A systematic review of economic evaluation studies and descriptive analysis of Spanish regional programmes]
2019	Norwegian Institute of Public Health (NIPH)	Organ donation with the use of normothermic regional perfusion in patients who die after cardiac and respiratory arrest after withdrawal of life-sustaining treatment
2019	Norwegian Institute of Public Health (NIPH)	Prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: best strategies for reducing the risk of severe toxicities caused by dihydropyrimidine dehydrogenase deficiency]
2019	Andalusian Health Technology Assessment Area (AETSA)	Clinical Utility of Procalcitonin–Guidance for initiation of antimicrobian treatment in patients admitted to the ICU
2019	The Regional Health Technology Assessment Centre (HTA-centrum)	Effectiveness and safety of microsurgical testicular sperm extraction in infertile men with non-obstructive azoospermia
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections. EUnetHTA-Report
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	POCT/ Point of Care Tests: D-Dimer and Troponin
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: antidiabetics]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Localized and disseminated stages of Lyme disease: from diagnosis to treatment, report in support of the diagnosis and treatment decision support tools]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards, updated on May 4th 2020 : guide to preventing and treating chemotherapy or radiotherapy-induced nausea and vomiting in adults]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in October 2019: lipid-lowering pharmacologic agents]
2019	Adelaide Health Technology Assessment (AHTA)	Faecal calprotectin testing in patients suspected of inflammatory bowel disease (IBD) presenting to primary care
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: post-tick bite antibiotic prophylaxis to prevent Lyme disease, report in support of the knowledge transfer tools, the Québec’s national medical protocol and the collective prescription template]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: mechanisms for accessing local services]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in August 2020: pharmacological treatment of nausea in a person receiving palliative care]